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Abstract
Background: Cigarette smoke has both pro-inflammatory and immunosuppressive effects. Both
active and passive cigarette smoke exposure are linked to an increased incidence and severity of
respiratory virus infections, but underlying mechanisms are not well defined. We hypothesized,
based on prior gene expression profiling studies, that upregulation of pro-inflammatory mediators
by short term smoke exposure would be protective against a subsequent influenza infection.
Methods: BALB/c mice were subjected to whole body smoke exposure with 9 cigarettes/day for
4 days. Mice were then infected with influenza A (H3N1, Mem71 strain), and analyzed 3 and 10 days
later (d3, d10). These time points are the peak and resolution (respectively) of influenza infection.
Results: Inflammatory cell influx into the bronchoalveolar lavage (BALF), inflammatory mediators,
proteases, histopathology, viral titres and T lymphocyte profiles were analyzed. Compared to
smoke or influenza alone, mice exposed to smoke and then influenza had more macrophages,
neutrophils and total lymphocytes in BALF at d3, more macrophages in BALF at d10, lower net
gelatinase activity and increased activity of tissue inhibitor of metalloprotease-1 in BALF at d3,
altered profiles of key cytokines and CD4+ and CD8+ T lymphocytes, worse lung pathology and
more virus-specific, activated CD8+ T lymphocytes in BALF. Mice smoke exposed before influenza
infection had close to 10-fold higher lung virus titres at d3 than influenza alone mice, although all
mice had cleared virus by d10, regardless of smoke exposure. Smoke exposure caused temporary
weight loss and when smoking ceased after viral infection, smoke and influenza mice regained
significantly less weight than smoke alone mice.
Conclusion: Smoke induced inflammation does not protect against influenza infection.
In most respects, smoke exposure worsened the host response to influenza. This animal model 
may be useful in studying how smoke worsens respiratory viral infections.
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Background
Cigarette smoke exposure is a major but preventable cause
of increased risk of lung infections in children and adults.
Smoke exposure is linked in adults to an increased inci-
dence and severity of asthma, impaired lung function and
airway inflammation. Exposure to cigarette smoke has
similar adverse effects to active smoking on lung infec-
tions, with young children at higher risk [1,2]. Nearly half
of the world's children breathe cigarette smoke at home
[1], and both pre- and post-natal smoke exposure are
linked to decreased lung function and increased risk and
severity of asthma and respiratory infections [1,2]. In
comparison to nonsmokers, smokers are at greater risk of
acquiring symptomatic common colds [3] and smokers
had greater infection rates and disease severity during an
influenza epidemic [4].
Influenza (flu) is a common and potentially serious viral
infection at all ages. It is caused by the influenza virus,
which has a segmented, negative strand RNA genome and
belongs to the Orthomyxoviridae family. Over three recent
successive winters in the UK, a total of 32% of patients
seeing a doctor with symptoms of respiratory infection
had PCR-detected influenza [5]. The role of inflammation
in the resolution of influenza infection remains contro-
versial, with evidence for both immune-mediated amelio-
ration [reviewed in [6]] and worsening [7-9] of the host's
overall condition.
Cigarette smoke has both immune activating and sup-
pressing activities [10] which can persist after smoking
cessation [11]. The effects of short term smoke exposure
on the acquisition and course of a respiratory virus infec-
tion, which reflects some of the incidental community
exposure to smoke, are not well understood. We and oth-
ers have previously described mouse models where smoke
exposure increases expression of factors likely to be
important in antiviral defence [12,13]. These factors
include key innate immune mediators and chemokines
such as tumor necrosis factor-α (TNF-α), macrophage
inflammatory protein-2 (MIP-2), monocyte chemoat-
tractant protein-1 (MCP-1) and interleukin-6 (IL-6). As
human influenza strains can be used to infect mice, and
influenza pathology in mice is similar to humans [6,14],
we chose a mouse model to study the effect of cigarette
smoke on host responses to influenza.
In this current study, we hypothesized that the induction
of such host defence factors and inflammatory mediators
in smoke exposed mice would largely protect against
harmful pathology from subsequent influenza infection.
However, we found that short term smoke exposure
before influenza infection led to an increase in most
aspects of inflammation, higher viral titres and greater
loss of body weight. Our results may improve the under-
standing of how smoke exposure worsens respiratory
virus infections.
Methods
Mice
Specific pathogen-free male BALB/c mice were obtained
from the Animal Resource Centre (Perth, Australia) at age
6–8 weeks. BALB/c mice were used as we have previously
shown them to be the most susceptible strain to smoke-
induced inflammation [12] and they are suitable for work
with influenza [6], including tetramer staining. Mice were
housed at 20°C on a 12-hr light/dark cycle in sterile micr-
oisolator cages and fed ad libitum with sterile chow and
water. All mouse procedures were approved by the Uni-
versity of Melbourne Animal Experimentation Ethics
Committee and complied with the standards of the
National Health and Medical Research Council of Aus-
tralia. After arrival, mice were acclimatized for 3 days.
Virus and cell culture procedures
The intermediate virulence H3N1 (Mem71) strain of
influenza A is a genetic reassortant of A/Memphis/1/71
(H3N2) × A/Bellamy/42 (H1N1) [15]. The virus was
grown in MDCK cells, which were maintained at 37°C/
5% CO2 in RPMI 1640 plus 2 mM L-glutamine, 2 mM
sodium pyruvate, 30 μg/ml gentamycin, 100 I.U./ml pen-
icillin, 100 μg/ml streptomycin and 10% v/v heat inacti-
vated FCS (all from Invitrogen). To grow virus stocks, 90%
confluent MDCK cells were washed twice in PBS and
infected with egg grown virus at 0.01 plaque forming units
(pfu)/cell, or mock infected with medium alone. After 1.5
hr inoculum was removed, cells were washed twice with
PBS and low protein, serum free medium (VP-SFM, Invit-
rogen) containing 0.5 μg/ml trypsin was added. Virus was
harvested 48 hr later, when there was extensive viral cyto-
pathic effect. Flasks were shaken to loosen cells, the
medium and cells were collected, briefly vortexed, sub-
jected to a low speed clearing spin and the clarified super-
natant stored in aliquots at -80°C.
Virus was quantitated by plaque assay in MDCK cells,
which were seeded at 4 × 106 cells per 6-well plate and
used the next day. Cells were washed twice in PBS, then
150 μl of virus diluted in serum-free RPMI was added to
duplicate wells. Plates were incubated at 37°C on a rocker
for 1 hr. Cells were overlaid with 3 ml per well of an equal
mix of double strength, serum free Leibovitz L15 medium
(Invitrogen) and 1.8% agarose (Sigma A-6013) prepared
in water (both held at 45°C). After 2 days at 37°C, cells
were fixed with 5% formaldehyde in saline for 4 hr, the
agarose was removed and cells stained for 45 min with
0.5% crystal violet (Sigma) in methanol. Plates were
rinsed in water and plaques counted.Respiratory Research 2008, 9:53 http://respiratory-research.com/content/9/1/53
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Cigarette smoke exposure & virus infection
Mice were subjected to whole body exposure of the smoke
of 9 Winfield Red cigarettes per day (delivered as 3 ciga-
rettes, 3 times/day) for 4 days, as previously described
[12]. This smoke exposure protocol causes acute inflam-
mation, but not acute lung injury and plasma corticoster-
one analysis indicated that mice are not unduly stressed
[16]. As nicotine reduces appetite, leading to weight loss
in smoke exposed mice, all mice were weighed daily dur-
ing smoke exposure and most days thereafter. The 4
groups in this study were no treatment, influenza (flu)
alone, smoke alone, and smoke and (then) influenza.
There was no further smoke exposure after influenza
infection.
Mice destined for influenza infection were anaesthetized
by penthrane inhalation (Medical Developments Aus-
tralia) and infected intranasally with 104.5 plaque forming
units of influenza in a 50 μl volume, diluted in serum free,
low protein medium (VP-SFM, Invitrogen). All mice,
including the no treatment and smoke alone groups, were
dissected at day 3 (peak) and day 10 (resolution) after the
influenza infection (d3, d10).
Dissection of mice
Mice were killed by an intraperitoneal ketamine/xylazine
overdose and bronchoalveolar lavage (BALF) collected as
previously described [12]. Lungs destined for virus titra-
tion or histology were not lavaged [17]. To determine
influenza virus titres in lungs, the entire lungs were
removed, weighed and homogenized briefly in serum-free
RPMI containing 30 μg/ml gentamycin, 100 I.U./ml pen-
icillin and 100 μg/ml streptomycin. Clarified homogenate
was snap frozen, stored at -80°C and used in plaque
assays. Viable cells in BALF were counted by fluorescence
microscopy [18] and cytospins prepared using 200 μl
BALF spun at 350 rpm for 10 min on a Cytospin 3 (Shan-
don, UK). BALF was briefly centrifuged to pellet cells, the
pellet was saved for flow cytometry and the clarified BALF
stored at -80°C for ELISAs and protease assays. Cytospin
slides were stained with DiffQuik (Dade Baxter, Australia)
and at least 500 cells per slide were differentiated into
eosinophils, neutrophils, lymphocytes and macrophages
by standard morphological criteria [19].
Protease expression and activity in BALF
Total gelatinase activity of non-concentrated, pooled
BALF was assayed by zymography, and net gelatinase
activity in BALF assayed by digestion of fluorescein cou-
pled gelatin, as previously described [12]. Densitometry
of zymography gels was done using Kodak 1D Image
Analysis Software. Net serine protease activity in BALF was
assayed as previously described [12].
Flow Cytometry
Cells from BALF pellets and mediastinal (draining) lymph
nodes (LNs) were pooled for each treatment group of 8
mice, and used at once without culture or stimulation.
Lymphocytes were purified from LNs using Lympholyte
(Cedarlane, Canada) as specified by the manufacturer.
BALF pellets were stained directly. All antibodies were
from PharMingen. Cells were washed in and then resus-
pended in 1 ml FACS buffer (PBS + 1% FCS) and counted.
Samples from influenza infected mice contained the most
cells and were diluted to 250,000 cells for each staining
reaction. All other samples were used undiluted. Cells
were stained for the constitutive markers CD3, CD4 and
CD8 and the activation markers CD25 (d3 only) or CD44
(d10 only). With d10 samples, influenza specific lym-
phocytes were stained with 10 μg/ml of the phycoerythrin
(PE)-coupled Kd NP 147–155 tetramer (sequence TYQR-
TRALV) and counterstained with peridinin chlorophyll
protein (PerCP)-coupled CD8. Cells were incubated with
antibody for 45 min at 4°C, washed twice in and resus-
pended in FACS buffer and paraformaldehyde (PFA) was
added to a final concentration of 1%. Data were acquired
on a BD FACSCalibur, gated on lymphocytes by standard
forward and side scatter properties, and set to acquire
10,000 gated events. As many gated events as possible
were acquired with no treatment mice, but this was
<10,000 with BALF stains. BD CELLQuest software was
used for acquisition and analysis. Results are expressed as
number of that type of cell in the pooled sample of 8
mice.
Real time PCR
Lungs were perfused free of blood with PBS, removed and
snap frozen. Extraction of total lung RNA using RNeasy
kits (Qiagen), reverse transcription with SuperScript III
(Invitrogen) and triplicate real time PCR reactions with
Applied Biosystems pre-developed assay reagents and 18S
rRNA internal control were done as previously described
[12]. Tissue pieces of equivalent size from lungs of the 4
mice (allocated for real time PCR and therefore not lav-
aged) in each treatment group were pooled prior to RNA
extraction. Relative quantities of mRNA for target genes is
expressed as a fold difference in comparison to no treat-
ment mice.
ELISAs
Tissue inhibitor of metalloprotease-1 (TIMP-1), macro-
phage inflammatory protein-2 (MIP-2), monocyte chem-
otactic protein-1 (MCP-1), interleukin-4 (IL-4), tumor
necrosis factor-α (TNF-α), granulocyte-macrophage col-
ony stimulating factor (GM-CSF) and interferon-γ (IFN-γ)
in BALF were quantitated using R&D Systems or PharMin-
gen kits as per manufacturer's instructions. Pooled sam-
ples from the 8 mice in each group were assayed inRespiratory Research 2008, 9:53 http://respiratory-research.com/content/9/1/53
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duplicate. IFN-α/β in BALF were quantitated by bioassay
[20].
Histology
Mouse lungs were perfusion fixed in situ via a tracheal can-
nula with 4% PFA at 200 mm H2O pressure. After 10 min,
the trachea was ligated, the lungs were left in situ for 1 hr,
then removed and immersed in 4% PFA for at least 24 hr.
After fixation of the lung tissue and processing in paraffin
wax, sections (3 – 4 μm thick) were cut and stained with
hematoxylin and eosin (H&E). Slides were viewed on a
Nikon E600 microscope and photographed at 200× mag-
nification with a Nikon DXM1200 camera running from
ACT-1 software.
Statistics
Data were analyzed and graphed using GraphPad PRISM
version 4.0. Data were generally analyzed using two-way
ANOVA, and when significance was achieved, a Bonfer-
roni post hoc test was used. Body weight comparisons
were analyzed using ANOVA with repeated measures, fol-
lowed by a post hoc Fisher's protected least significance
difference test. Viral titres in lung were compared using an
unpaired Student's two-tailed t-test. Unless otherwise
stated data are presented as mean +/- standard error of
mean (SEM) for at least 8 mice/group. Probability values
less than 0.05 were considered significant. The symbol *
indicates a significant change (p < 0.05); ** p < 0.01,
***p < 0.001, by ANOVA and Bonferroni test.
Results
Weight changes
We have previously shown that over this 4 day smoke pro-
tocol, mice lose ~6–10% of their body weight, due to nic-
otine-induced changes in brain neuropeptide Y which led
to reduced food intake [16,21]. Figure 1 shows mice body
weights. While this strain of influenza does not cause
weight loss in mice, it replicates rapidly to high titres and
induces a strong immune response; hence, it is considered
an intermediate virulence strain [15]. No mice had any
obvious illness. Both groups of smoke exposed mice
regained weight as soon as smoke exposure stopped, indi-
cating that loss of weight in smoke exposed mice was due
to transient appetite suppression. However, smoke and
influenza mice consistently regained less weight than
smoke alone mice (p < 0.05). Influenza alone mice gained
significantly more weight than smoke and influenza mice
at all time points (p < 0.05). Weights of no treatment mice
(not shown) continued to rise and were similar to influ-
enza alone mice.
Cellular influx into BALF
Influenza caused a significant increase in total viable cells
in BALF at d3, more so in smoke and influenza mice (Fig-
ure 2a). Influenza caused a macrophage influx at d3
which was higher with prior smoke exposure, while
smoke alone mice at d3 and d10 had more macrophages
in BALF than no treatment mice (Figure 2b). Macrophage
numbers were higher in influenza alone mice at d10 than
at d3, with prior smoke exposure leading to significantly
more macrophages than in influenza alone mice.
Influenza caused BALF neutrophilia at d3 which was
higher in smoke and influenza mice (Figure 2c). Smoke
exposure prior to influenza infection was associated with
an earlier peak and earlier decline of total lymphocytes in
BALF, than in influenza alone mice (Figure 2d). Eosi-
nophil numbers in BALF were consistently very low (not
shown). Overall, smoke exposure generally increased
inflammatory cells in BALF, even though at the d10 time
point, mice had not been smoke exposed for 11 days.
To exclude the possibility that inflammation in influenza
infected mice was due to cell proteins in the virus stock,
separate groups of mice were intranasally inoculated with
clarified supernatant of mock-infected MDCK cells, made
at the same time as the virus stock, using the same media
Change in body weight of mice during the experimental  period Figure 1
Change in body weight of mice during the experi-
mental period. Influenza ( ; n = 12), smoke alone ( ; n = 8) 
and smoke and influenza (-  -, n = 12). Mice lost weight 
while smoke exposure was underway, and once exposure 
stopped, weight was regained but this was impaired in smoke 
and influenza mice. Mice were first weighed 3 days before 
smoke exposure began and weights are expressed as mean 
change from this starting weight, +/- SEM. Data were ana-
lyzed by one way ANOVA with repeated measures followed 
by a post hoc Fisher's protected least significant difference 
test. The * symbol indicates a statistically significant differ-
ence in mean weight between smoke alone and smoke and 
influenza mice, at that time point. The # symbol indicates a 
statistically significant difference in mean weight between 
influenza alone and smoke and influenza mice at that time 
point.
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and adjusted to the same protein content. With or without
prior smoke exposure, inoculation of mice with MDCK
supernatant caused only a very small rise in inflammatory
cells in BALF (results not shown) indicating that influenza
infection caused specific, virus-induced inflammation.
Lung virus titres
These were determined by plaque assay of lung homoge-
nates (Figure 3). Smoke and influenza mice had signifi-
cantly higher virus titres at d3 than influenza alone mice.
At d10 both groups of mice had no detectable virus in
lungs (not shown).
Lung proteases
In most respects, influenza increased protease activity in
lungs and this was amplified by cigarette smoke. Zymog-
raphy separates active proteases from complexes with
inhibitors, indicating total active protease [22]. Major
bands of gelatinase activity detected were at ~90 and 60
kDa, corresponding to MMP-9 and MMP-2 respectively
[22]. Total gelatinase (Figure 4a) activity in BALF was ele-
vated at d3 in influenza alone mice, more so with prior
smoke exposure (Figures 4c and 4d). Total gelatinase
activity in BALF at d10 was much lower for all groups of
mice (not shown). The major bands of caseinolytic activ-
ity at d3 were at ~90 and 60 kDa (Figure 4b). Densitome-
try indicated that the 90 kDa protease was fairly abundant
in BALF of uninfected mice, with and without smoke
Total and differential BALF cell counts Figure 2
Total and differential BALF cell counts. Smoke increased the influx of total cells (a), macrophages (b) and neutrophils (c) 
into the BALF of influenza infected mice, and altered the profile of lymphocyte influx (d). Clear boxes denote mice not infected 
with influenza and dark boxes denote mice infected with influenza, n = 8 in all groups. Data were analyzed by two-way 
ANOVA, and when significance was achieved, a Bonferroni post hoc test was used. The symbol * indicates a significant change 
(p < 0.05); ** p < 0.01, ***p < 0.001.
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exposure (Figure 4e) but was most active in BALF of
smoke and influenza mice at d3. This protease had the
same relative abundance across groups at d10, but less
overall activity (not shown). The 60 kDa caseinolytic pro-
tease was induced by influenza at d3, more so with prior
smoke exposure (Figure 4f); this protease was undetecta-
ble at d10.
The fluorogenic substrate assay for net gelatinases meas-
ures predominantly MMP-2 and MMP-9, while the assay
for net serine proteases mostly detects neutrophil elastase
(the major serine protease in BALF). In contrast to zymog-
raphy, proteases bound to endogenous inhibitors will not
be detected in these assays. Compared to the influenza
alone group, mice exposed to smoke and then influenza
had reduced net gelatinase activity in BALF (Figure 4g) but
increased net serine protease activity at d3 (Figure 4h).
Smoke reduced net gelatinase activity in both virus
infected and uninfected mice at d3. Gelatinase activity was
low in all groups at d10. For both influenza infected and
uninfected mice, smoke exposure was associated with
higher net serine protease activity in BALF at d10.
Lung mRNAs encoding the gelatinases MMP-2 and MMP-
9, as well as MMP-7 (matrilysin) and MMP-12 (macro-
phage metalloelastase) were quantitated by real time PCR
(Figure 4i). MMP-2 was slightly increased in smoke and
influenza mice at d3. Smoke and influenza mice had
increases in gene expression of MMP-7 at d3 only and of
MMP-9 at d10 only. MMP-12 mRNA levels were increased
in all mice, especially smoke and influenza mice, at d3
only.
Antiproteases
TIMP-1 protein was elevated in BALF of influenza infected
mice at d3, more so if mice were smoke exposed prior to
influenza infection (Figure 5a). At d10, TIMP-1 was
present in BALF in low amounts for all mice. In contrast,
smoke exposure reduced the influenza-associated rise in
lung TIMP-1 mRNA at d3 (Figure 5b). Lung mRNA levels
of TIMP-2 and TIMP-3 were determined by real time PCR
but all groups had little change relative to no treatment
mice (not shown).
Flow cytometry of lymphocytes
Some key types of T cells were quantitated in BALF and
LNs by FACS. Smoke and influenza mice had fewer CD3+
CD4+ (helper T) lymphocytes and CD3+ CD8+ (cytotoxic
T lymphocytes) in their LNs, at both d3 and d10, than
influenza alone mice (Figures 6b and 6d). However, at
d10, smoke and influenza mice had many more CD4+
and CD8+ T cells in BALF, than influenza alone mice (Fig-
ures 6a and 6c). Smoke alone mice had more CD4+ T cells
in BALF at d10 than no treatment mice.
Activation of T cells in BALF at d3 was assessed by CD25α
staining [23]. In mice not subjected to smoke exposure,
intensity of CD25α staining on both CD4+ and CD8+
cells in BALF was low for influenza and no treatment
mice. Smoke exposed mice had greater numbers of both
CD4+ and CD8+ cells that stained more intensely for
CD25, particularly with influenza infection (Figure 6e). In
LNs, all groups had similar CD25 staining on CD4+ and
CD8+ cells, regardless of smoke exposure (results not
shown).
Staining for the CD44 activation marker was done at d10.
Influenza alone mice had slightly more CD4+ CD44+ and
CD8+ CD44+ cells than no treatment mice in BALF, espe-
cially with smoke exposure. Neither virus nor smoke
altered intensity of CD44 staining in LNs (results not
shown).
Tetramer staining
This was used to detect influenza specific cytotoxic T cells
which appear in BALF around 7 days post infection [24].
Staining at d10 showed that smoke exposure before influ-
enza caused a large increase in virus specific CD8+ T cells
in BALF (Figure 7a), most of which were positive for
CD44 (Figure 7b). In LNs of influenza infected mice, there
were very few CD8+ tetramer+ cells, regardless of smoke
exposure (not shown).
Virus titres in mouse lung Figure 3
Virus titres in mouse lung. Titres were determined by 
plaque assay of individual lung homogenates in MDCK cells, n 
= 8 per group. Prior smoke exposure was linked to higher 
virus titres. Data are mean +/- SEM, ***p < 0.001, Student's 
two-tailed t-test. Results shown are for the d3 time point, at 
d10 virus was undetectable in both smoke and influenza and 
influenza alone mice.
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Lung protease activity and gene expression Figure 4
Lung protease activity and gene expression. In bar graphs clear boxes denote mice not infected with influenza and dark boxes denote mice infected 
with influenza. Panels a-h show protease activity in BALF. (a) Zymography of gelatinase activity at d3, (b) zymography of caseinolytic activity at d3 (the 
molecular mass of protein standards in kDa is indicated on the left side), (c) densitometry of MMP-9, (d) densitometry of MMP-2, (e) densitometry of 90 
kDa caseinolytic protease, (f) densitometry of 60 kDa caseinolytic protease, (g) net gelatinase activity and (h) net serine protease activity in BALF, deter-
mined by fluorometric and colorimetric assays (respectively) in 96 well plates. BALFs of the 8 mice in each group were pooled for all of these assays. For 
the assays in panels g and h, this graph is representative of two assays run with the same samples, and every sample was run in triplicate. Panel i shows 
quantitation of relative mRNA units of proteases in mouse lung. Legend:   = influenza alone mice,   = smoke alone and -  - = smoke and influenza mice. 
Tissue pieces of equivalent size from lungs of the 4 mice in each treatment group were pooled prior to RNA extraction, and the cDNA was used in tripli-
cate reactions. Fold changes are expressed relative to mRNA levels in lungs of no treatment mice.
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Lung inflammatory mediators
ELISA was used to quantitate protein levels of inflamma-
tory mediators in BALF, and/or real time PCR was used to
quantitate mRNA levels of inflammatory mediators in
lung (Figures 8 &9). Smoke exposure (without viral infec-
tion) was generally associated with higher protein levels
of cytokines (e.g. TNF-α, MIP-2, GM-CSF, IFN-γ) in BALF
than in no-smoke mice, especially at d10 (Figure 8a–d).
We have previously shown that TNF-α mRNA in periph-
eral fat of smoke exposed mice was unchanged, suggesting
that effects of smoke are largely confined to the lung [16].
Influenza increased d3 protein levels of the neutrophil
chemoattractant MIP-2 (Figure 8b) and MCP-1 (Figure
8e), more so with prior smoke exposure. Influenza infec-
tion alone did not increase other cytokines in BALF. IL-4
protein was undetectable in any sample (data not shown).
When comparing influenza alone to smoke and influenza
mice, smoke reduced the influenza-associated induction
of mRNA encoding TNF-α, IL-1β, IL-6, IP-10 (interferon
inducible protein 10) and granzyme B at d3, MIG
(monokine induced by gamma-interferon) at d10 and
granzyme K (slightly) at both d3 and d10 (Figures 8 &9).
Smoke increased the influenza-associated induction of
mRNA encoding IL-17 (Figure 9). The moderate induc-
tion of granzyme A mRNA in influenza infected mice was
unaltered by smoke. Granzyme C mRNA was undetecta-
ble in any group (not shown).
Histology
Figure 10 shows H&E stains of lung sections from mice
killed at d3. We have previously reported that this smoke
exposure protocol causes mild lung inflammation, but
not acute lung injury [12]. The top four sections (A, B, E
and F) illustrate perivascular inflammation while the
lower four sections (C, D, G and H) illustrate inflamma-
tory cell exudates. Smoke alone (E, G) caused a mild
inflammatory reaction comprising subtle perivascular and
alveolar infiltrates of monocytes/macrophages and neu-
trophils. Influenza alone (B, D) caused considerable
inflammation, with prominent inflammatory cell cuffing
around bronchi and in the parenchyma, with some air-
ways having small volumes of exudates containing mucus
(detail revealed by periodic acid Schiff/Alcian Blue stain-
ing, not shown) and leukocytes. Inflammation was more
apparent in smoke and influenza mice (F, H) with prom-
inent mucus exudates in the airways. At d10 smoke and
influenza mice had minor inflammation, but in all other
groups of mice, inflammation had fully resolved (results
not shown).
Discussion
The hypothesis of this study was that short term smoke
exposure of mice would activate pro-inflammatory medi-
ators, leading to reduced viral replication and conse-
quently, less pathology from influenza infection.
However, prior smoke exposure generally led to increased
inflammation and pathology after influenza infection.
This was reflected in impaired weight regain once smoke
TIMP-1 protein in BALF Figure 5
TIMP-1 protein in BALF. TIMP-1 was quantitated by ELISA (a) and real time PCR of lung mRNA (b). Clear boxes denote 
mice not infected with influenza and dark boxes denote mice infected with influenza. BALFs of the 8 mice in each group were 
pooled and used in duplicate ELISAs for TIMP-1. Legend in (b):   = influenza alone mice,   = smoke alone and -  - = smoke and 
influenza mice. Tissue pieces of equivalent size from lungs of the 4 mice in each treatment group were pooled prior to RNA 
extraction, and the cDNA was used in triplicate reactions. Fold changes are expressed relative to mRNA levels in lungs of no 
treatment mice.
d3 No Smoke d3 Smoke d10 No Smoked10 Smoke
0
500
1000
1500
2000
2500
3000
3500
a
T
I
M
P
-
1
 
i
n
 
B
A
L
F
,
 
p
g
/
m
l
Day 3 Day 10
0
1
2
3
4
5
6
7
8
9
10
11
12
TIMP-1 b
Days since flu
R
e
l
a
t
i
v
e
 
m
R
N
A
 
u
n
i
t
sRespiratory Research 2008, 9:53 http://respiratory-research.com/content/9/1/53
Page 9 of 17
(page number not for citation purposes)
Flow cytometry quantitation of T lymphocytes Figure 6
Flow cytometry quantitation of T lymphocytes. CD3+ CD4+ lymphocytes in (a) BALF & (b) LNs, and CD3+ CD8+ lym-
phocytes in (c) BALF and (d) LNs were quantitated by flow cytometry. Clear boxes denote mice not infected with influenza 
and dark boxes denote mice infected with influenza. The y-axis counts represent the total figure for the pooled samples of 8 
mice per treatment. Figure 6(e) is a histogram presentation of CD4+CD25+ and CD8+ CD25+ cells in BALF (pooled samples 
of 8 mice per group), with and without smoke exposure.
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exposure stopped, more total cells and macrophages in
BALF at d3 and d10, more neutrophils in BALF at d3,
higher viral titres at d3, generally higher protease activity
in BALF and greater lung inflammation, as assessed by his-
tology. Smoke before influenza infection led to more
influenza specific cytotoxic T lymphocytes in BALF at d10.
In line with other reports that cigarette smoke has both
pro- and anti-inflammatory effects [10], some aspects of
inflammation and pathology were reduced in mice sub-
jected to smoke exposure before influenza infection. For
example, net gelatinase activity in BALF and numbers of
CD4+ and CD8+ lymphocytes in LNs were reduced in
mice that were smoke exposed before influenza infection,
in comparison to mice that were not smoke exposed
before influenza infection.
In this study we have adopted a previously validated
smoke exposure regime which achieves blood carboxy-
haemoglobin levels comparable to those found in regular
human smokers [25] and smoke particulate matter levels
comparable to those reported by other research groups
using mouse models [26,27]. It should be noted however
that smoke exposure in humans is highly variable.
Accordingly, there is no way to "standardize" exposure in
mice. In addition to achieving carboxyhaemoglobin levels
similar to smokers and particulate densities known to be
relevant, our smoke exposure system also achieves expo-
sure to nicotine levels high enough to suppress appetite
[16]. Appetite regulation is a major motivation to smoke
in humans. In our model there is only minor induction of
systemic inflammation, as smoke did not change TNF-α
transcripts in adipose tissue [16] and on smoking cessa-
tion animals immediately regain weight (Figure 1). Con-
sidered in concert with the mild lung pathology we
observe in smoke alone mice, this indicates that the
model is driven principally by local lung responses to
smoke. The lack of acute lung injury, also observed in his-
topathology, is consistent with the weak systemic changes
we have observed.
This novel animal model will be useful in studying the
interaction of smoke, influenza and perhaps other respira-
tory viruses such as respiratory syncytial virus (RSV).
There are only a few papers describing infection of smoke
exposed mice with influenza or other respiratory viruses,
and the great variation in properties of different influenza
strains further complicates comparisons. The focus of
older studies, such as pre-cancerous lesions in the lung
[28] and effects of smoke on immune responses to a sec-
ondary heterotypic influenza infection [29] were different
to the viral and immune parameters that we explored.
More recently, Robbins et al. profiled influenza infection
of smoke exposed mice [30]. Direct comparisons between
their study and ours are limited as Robbins et al. used the
C57BL/6 strain of mice, which is less susceptible to smoke
[12] a different (H1N1, A/FM/1/47) strain of influenza,
and a longer smoking protocol. Their trend observation
that prior smoke exposure increased inflammation and
worsened outcomes from high dose influenza infection
was similar to our general conclusions.
Lung proteases, mainly matrix metalloproteases and the
serine protease neutrophil elastase, are essential for nor-
mal immunity and repair of damaged tissue [31]. TIMPs
are the main inhibitors of MMPs; TIMPs have other
diverse roles in promoting cell growth and regulating
apoptosis [32,33]. Proteases normally promote leukocyte
extravasation, activation of inflammatory mediators,
Tetramer staining of influenza specific CD8+ T cells Figure 7
Tetramer staining of influenza specific CD8+ T cells. This was used to detect (a) influenza specific CD8+ T lymphocytes 
in BALF, and (b) influenza specific CD8+ T lymphocytes in BALF that are CD44+ positive. Clear boxes denote mice not 
infected with influenza and dark boxes denote mice infected with influenza. The y-axis counts represent the total figure for the 
pooled samples of 8 mice per treatment.
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Cytokine quantitation in BALF and lung Figure 8
Cytokine quantitation in BALF and lung. Protein levels in BALF were determined by ELISA (left) while mRNA levels of 
the corresponding cytokine in lung were determined by real time PCR (a-c only, right). BALFs of the 8 mice in each group 
were pooled and used in duplicate ELISAs. Clear boxes denote mice not infected with influenza and dark boxes denote mice 
infected with influenza. Legend:   = influenza alone mice,   = smoke alone and -  - = smoke and influenza mice. Tissue pieces 
of equivalent size from lungs of the 4 mice in each treatment group were pooled prior to RNA extraction, and the cDNA was 
used in triplicate reactions. Fold changes are expressed relative to mRNA levels in lungs of no treatment mice. Cytokines 
assayed were (a) TNF-α, (b) MIP-2, (c) GM-CSF, (d) IFN-γ and (e) MCP-1.
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Quantitation of relative mRNA units of inflammatory mediators in mouse lung Figure 9
Quantitation of relative mRNA units of inflammatory mediators in mouse lung.   = influenza alone mice,   = smoke 
alone and -  - = smoke and influenza mice. Tissue pieces of equivalent size from lungs of the 4 mice in each treatment group 
were pooled prior to RNA extraction, and the cDNA was used in triplicate reactions. Fold changes are expressed relative to 
mRNA levels in lungs of no treatment mice.
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H&E stains of lung sections from mice killed at d3 Figure 10
H&E stains of lung sections from mice killed at d3. The left panel (A-D) shows sections from mice that were not smoke 
exposed; these were no treatment at all mice (A and C), and influenza infected mice (B and D). The right panel (E-H) shows 
sections from mice that were smoke exposed; these were smoke alone mice (E and G) and smoke + influenza mice (F and H). 
All sections were magnified 200× and the scale bar (lower left corner of all figures) denotes 50 μm. The lungs of 4 mice from 
each treatment group were processed for histology and results shown were typical for the group.
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mucus secretion and products of proteolysis are chemoat-
tractants for inflammatory cells [31]. Hence, we hypothe-
sized that the general increase in lung proteases observed
with our short term smoke exposure protocol [12] may
lead to an increased antiviral response.
Influenza infected mice had raised serine protease activity
in BALF which was higher with prior smoke exposure. As
neutrophils are the main source of serine proteases in
BALF, this was expected. It is not clear why serine protease
activity in BALF of smoke alone mice was lower at d3 and
increased at d10, although changes in specific antipro-
teases could be a factor. Zymography showed that smoke
before influenza infection led to higher total activity of
MMP-2, MMP-9 and caseinolytic proteases in BALF at d3.
The apparent reduction in net gelatinase activity in BALF
of smoke and influenza mice at d3, in comparison to
influenza alone mice, is probably due to increased TIMP-
1 activity. Protease activity is regulated at multiple levels,
including transcription and post-translational cleavage
[31], so it was interesting that prior smoke exposure
altered transcriptional induction of proteases and TIMP-1
after influenza infection.
Inflammatory mediators were quantitated in BALF and
lung by ELISA and real time PCR respectively, with the
goal of understanding the inflammatory cell influx. Mac-
rophages and neutrophils in particular are essential for
clearance of infected and damaged tissue but their media-
tors may cause harm [34,35]. The rise in macrophages
from d3 to d10 could be due to local macrophage prolif-
eration and/or chemotaxis in response to matrix break-
down products [36], consistent with the induction of
some proteases that we observed.
We have previously found that this short term smoke
exposure protocol increased mRNA levels of many pro-
inflammatory mediators in lung and/or alveolar macro-
phages [12]. In the current study, mRNA and protein lev-
els for the same mediator were often not concordant;
many of these inflammatory mediators may be subject to
post-transcriptional regulation. Macrophage and neu-
trophil counts in BALF at d3 were in line with MCP-1 and
MIP-2 levels (respectively). At the protein and especially
at the mRNA level, many cytokines have a short half life
[23]. Precise determination of cytokine mechanisms may
have required more time points, and analysis of other
samples such as lung homogenate or serum. It was inter-
esting that protein amounts of the pro-inflammatory
cytokines TNF-α, MIP-2, GM-CSF and IFN-γ in BALF were
generally higher at both time points in BALF of smoke
alone versus no treatment mice or smoke and influenza
mice. This may be because smoke persistently activates
some immune signalling pathways, even when smoking
stops [37].
TNF-α and GM-CSF promote mobilization, activation
and survival of neutrophils and macrophages [23]. TNF-α
is a key factor in the lung inflammatory cell influx and
matrix breakdown seen in smoke exposed mice [38]. In
our study, influenza induced mRNA for these cytokines at
d3, with small changes in mRNA after smoke exposure.
TNF-α and GM-CSF proteins were absent or present in
low amounts in BALF of influenza infected mice, except
for smoke and influenza mice at d10, which may reflect
production by macrophages and lymphocytes. However,
GM-CSF can be hard to detect as the protein is rapidly
cleared by receptor mediated internalization [39].
The higher viral titres in smoke and influenza mice at d3
may have been due to smoke reducing the interferon
(IFN) response. However, quantities of IFN-α/β in BALF
were low, with a small but insignificant increase in smoke
and influenza mice at d3 (not shown). IFN-α/β in BALF
may have already peaked and subsided by d3, and/or lung
homogenate or serum may be a better sample. In contrast,
IFN-γ protein in BALF showed little change in our study,
aside from a rise in smoke alone mice at d10. IFN-γ is crit-
ical in antiviral immunity and smoke-induced macro-
phage activation [40,41]. Both CD4+ and CD8+ T cells
produce IFN-γ, and smoke reduced the number of these
cells in LNs of influenza infected mice at both d3 and d10,
while smoke and influenza mice had very high numbers
of both types of T cells in BALF at d10.
BALF counts of neutrophils and macrophages in influenza
infected mice were increased by prior smoke exposure.
The failure of these "extra" cells to reduce viral replication
could mean that smoke impaired the function of these
and perhaps other immune cells. Similarly, in human
smokers numbers of alveolar macrophages are increased,
yet their phagocytic ability and output of some pro-
inflammatory mediators is reduced [reviewed in [10]].
CD8+ T cells are critical for clearance of respiratory
viruses, but depending on the number of CD8+ T cells and
overall immune status, these cells may cause severe lung
pathology [42]. CD8+ T cells are critical but insufficient
for protective memory responses to influenza in mice [24]
and are also implicated in tissue damage in human smok-
ers [43] and smoke exposed mice [44]. CD4+ T cells are
implicated in mucus hypersecretion in smokers [45] and
are important but not essential for clearance of influenza
in mice [46].
We found that prior smoke exposure altered the T cell
response to subsequent infection with influenza. In par-
ticular, the number of influenza specific, activated T cells
in BALF at d10 was greatly increased by smoke exposure.
Smoke exposure before influenza was associated with
fewer CD4+ and CD8+ lymphocytes in LNs at both d3Respiratory Research 2008, 9:53 http://respiratory-research.com/content/9/1/53
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and d10, and a large increase in both types of lymphocytes
in BALF at d10. Many cell types, including CD8+ T cells,
make IP-10. IP-10 has a role in homing and retention of T
cells [47] and is also implicated in smoke-induced lung
damage in humans [40] and mice [44], as it stimulates
macrophages to release MMP-12. MIG is both made by
and is a chemoattractant for T lymphocytes [23], and it
also stimulates macrophages to release MMP-12 [40]. We
found that smoke reduced the influenza-associated induc-
tion of lung mRNA encoding MIG at d10 and of IP-10 at
d3, which could explain how smoke modified the kinetic
profiles of CD4+ and CD8+ T cells. If these mRNA
changes in lung led to protein changes in BALF, it would
be interesting that activated CD8+ T cells were retained in
BALF of smoke and influenza mice despite reduced levels
of typical T cell retention mediators. As smoke also
reduced mRNA expression of the T cell mediators,
granzymes B and K in lungs of influenza infected mice,
this could mean that CD8+ T cells of these mice have
impaired function.
With this smoking protocol we previously observed
increased mRNA encoding both TGF-β and IL-6 [12],
which cross regulate the balance between anti-inflamma-
tory regulatory T cells (Treg) and pro-inflammatory Th17
lymphocyte subsets. TGF-β is involved in proliferation of
Treg [48] and suppression of CD8+ T cell activity by Treg
[49]. Cells that are CD3+CD4+ CD25+ are typically acti-
vated T helper cells [50]. This marker profile also occurs
on Treg, which also express Foxp3 and dampen inflamma-
tion [23]. Staining intensity for CD25 in BALF at d3 was
slightly less in influenza alone mice (relative to no treat-
ment mice) but higher with smoke exposure, especially
after influenza infection. While we did not conclusively
identify these CD25+ cells as Treg, we speculate that
smoke exposure led to more Treg, which may have con-
tributed to greater viral replication via reduced CD8+ T
cell activity. This remains to be formally tested.
The precise pathological and molecular basis of how
smoke modifies influenza infection is the subject of ongo-
ing studies. Preliminary work with small group sizes and
many time points strongly suggested that smoke did not
simply move the kinetics of the inflammatory response
(not shown). The higher virus titres at d3 in smoke and
influenza mice could also be due to effects of smoke on
natural killer cells. Another possible factor in the smoke-
associated increase in influenza titres relates to the need
for trypsin or related proteases for the cleavage of the viral
haemagglutinin [6]. If this does not occur, new viral parti-
cles cannot spread to infect nearby cells. As cigarette
smoke induces oxidative stress [51], which can inactivate
antiproteases [52], cigarette smoke could lead to more
trypsin in the lung and hence more efficient viral replica-
tion.
Conclusion
Short term cigarette smoke exposure induces inflamma-
tory mediators and cells known to be important in antivi-
ral immunity. We have developed a novel mouse model
for short term smoke exposure followed by infection with
live influenza. We hypothesized that smoke would cause
an overall activation of pro-inflammatory mediators,
leading to a more efficient antiviral response. However, in
most respects prior smoke exposure worsened influenza
infection. This mouse model may be useful in under-
standing the balance of pro- and anti-inflammatory activ-
ities of smoke, and why smoke increases the incidence
and severity of respiratory virus infections.
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